Tele-Rehabilitation Pilot Evaluation Study
Launched by NATIONAL UNIVERSITY OF SINGAPORE · Jan 23, 2018
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
This is a 12-week quasi-experimental trial of a tele-rehabilitation program involving seven sites and up to 600 adults in Singapore.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 21 years of age
- • Admitted into an inpatient or outpatient rehabilitation unit, nursing home or day care centre for an acute or chronic disability
- • Deemed by any members of the multi-disciplinary rehabilitation team to potentially able to safely receive and benefit from rehabilitation post-discharge
- • Cognitively able to understand and follow instructions (the Abbreviated Mental Test's score of 6 or above (out of 10).
- Exclusion Criteria:
- • Patients with previous seizure episodes
- • Patients with limb musculoskeletal pain of at least moderate intensity (visual analogue Scale \> 6 out of 10)
- • Patients with pacemakers.
About National University Of Singapore
The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Miho Asano, PhD
Principal Investigator
National University of Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials